课题基金 / 基金详情

4-Hydroxyphenylpyruvate Dioxygenase and Tyrosinemia

4-Hydroxyphenylpyruvate Dioxygenase and Tyrosinemia
4-羟基苯丙酮酸双加氧酶和酪氨酸血症
批准号:
6624213
负责人:
GRAHAM Rodney MORAN
金额:
$19.78万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-15 至 2006-02-28

项目摘要

项目成果

GRAHAM Rodney MORAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Iron-dependent non-heme oxygenases are the specific focus of this research. These enzymes catalyze vital metabolic and catabolic reactions throughout mammalian metabolism. The initial intent is to develop a fundamental understanding of the chemistry of these enzymes by the identification of the transient oxygen intermediates that are generated during catalysis. The long-term objective is to find evidence for the geometry of transition states for specific catalytic steps such that stable transition state mimics can be developed as inhibitory therapeutic agents to control the flux through key metabolic pathways. Initially, the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD) has been selected for investigation. This enzyme exemplifies many of the catalytic functions of other FeII-dependent non-heme dioxygenases such as aromatic oxygenation, oxidative decarboxylation and substituent migration. Furthermore, it is one of the few alpha-keto acid-dependent oxygenases for which the crystal structure is known. Moreover, it has become a paradigm example of the ability to alleviate metabolic disorders through selective enzymatic inhibition. Type 1 Tyrosinemia, is caused by a deficiency of active fumarylacetoacetase, an enzyme that catalyzes the final step in the pathway for the catabolism of tyrosine. In the absence of treatment this disease is often fatal in the first year of life and always prior the completion of the first two decades. It is known, however, that the inhibition of HPPD which catalyzes the second step of this pathway is, in most cases, an effective treatment for type 1 Tyrosinemia. Part of the intent of this research is that the mechanism of this inhibition be understood in the context of catalytic events of the enzyme. The experimental approach will be to combine steady state and pre-steady state analyses with the selective use of substrate analogs, isotopic labels and mutagenesis and crystallography to test mechanistic hypotheses on the basis of rate constant modulation and structure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2017 Enzymes, Coenzymes and Metabolic Pathways Gordon Research Conference and Gordon Research Seminar
  • 批准号:
    9390140
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2017
  • 负责人:
    GRAHAM Rodney MORAN
  • 依托单位:
4-Hydroxyphenylpyruvate Dioxygenase and Tyrosinemia
  • 批准号:
    6731209
  • 项目类别:
  • 资助金额:
    $19.77万
  • 财政年份:
    2002
  • 负责人:
    GRAHAM Rodney MORAN
  • 依托单位:
4-Hydroxyphenylpyruvate Dioxygenase and Tyrosinemia
  • 批准号:
    6744999
  • 项目类别:
  • 资助金额:
    $6.13万
  • 财政年份:
    2002
  • 负责人:
    GRAHAM Rodney MORAN
  • 依托单位:
4-Hydroxyphenylpyruvate Dioxygenase and Tyrosinemia
  • 批准号:
    6858761
  • 项目类别:
  • 资助金额:
    $19.75万
  • 财政年份:
    2002
  • 负责人:
    GRAHAM Rodney MORAN
  • 依托单位:
海外基金